The government has moved to allay concerns about a potential crisis among HIV/AIDS patients following US President Donald Trump's recent directive.
In one of his first executive orders in his second term as President, Trump suspended the supply of HIV drugs to countries supported by the United States Agency for International Development (USAID).
During a press conference on Wednesday, January 29, Director-General for Health, Dr Patrick Amoth, reassured the public by addressing concerns and confirming that the government has a sufficient supply of antiretrovirals (ARVs) that will remain consistently available. "I want to assure Kenyans that we have sufficient stock of HIV commodities, including ARVs and testing commodities.
We have strengthened our supply chain pipeline to ensure continuous availability," Amoth affirmed.
